Gynecologic Cancer
From the Journals
Heavy toll from ongoing cancer referral delays
Feature
Cancer patient organizations critically affected by pandemic
Conference Coverage
Lipophilic statins linked to lower mortality in ovarian cancer
Lipophilic statin use was associated with a 43% reduction in mortality.
From the Journals
Higher death risk with minimally invasive surgery in gynecologic cancers
Conference Coverage
Sequential chemoradiation improves DFS in early-stage cervical cancer
The 3-year disease-free survival rate was significantly higher among patients who received sequential chemoradiation than among patients who...
Conference Coverage
Vulvar melanoma is increasing in older women
Survival is markedly worse after age 60, when the nodular subtype prevails.
From the Journals
American Cancer Society update: ‘It is best not to drink alcohol’
Expert Commentary
ASCCP guidelines for managing abnormal cervical cancer tests: What’s new?
They’ve traded in algorithms for risk, and there will soon be a new app to streamline navigation of the guidelines
Conference Coverage
Secondary surgery extends OS in recurrent ovarian cancer
Cytoreductive surgery provided a significant survival benefit over chemotherapy alone for patients with favorable presurgical predictive scores....
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
Gynecologic Oncology Consult
Should all patients with advanced ovarian cancer receive frontline maintenance therapy?
Is maintenance therapy worthwhile for all patients, and is it good value?